Insulin Resistance and the Metabolic Syndrome

  • Rochelle L. Chaiken


Insulin resistance is defined as an impaired biological response to the actions of insulin.1 It was classically described as resistance to insulin mediated glucose uptake in peripheral cells. However, as the metabolic and mitogenic processes of insulin action are better understood, abnormal insulin action in these pathways is being elucidated. Thus, impaired biological response to insulin may be associated with either endogenous or exogenous insulin and can be quantified by changes in several metabolic processes, including carbohydrate, lipid, or protein metabolism or by changes in mitogenic processes.2


Insulin Resistance Metabolic Syndrome Insulin Sensitivity Growth Hormone Deficiency Normal Glucose Tolerance 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    American Diabetes Association. Consensus Development Conference on Insulin Resistance. Diabetes Care. 21: 310–314, 1998.Google Scholar
  2. 2.
    Mattaei, S, Stumvoll M, Kellerer M, Haring, H. Pathophysiology and pharmacological treatment of insulin resistance. Endocrine Reviews 21: 585–618, 2000.CrossRefGoogle Scholar
  3. 3.
    Himsowrth HP, Kerr RB. Insulin-sensitive and insulin-insensitive types of diabetes mellitus. Clin Sci 4: 119–152, 1939.Google Scholar
  4. 4.
    Cahill GF. Physiology of insulin in man. Diabetes 20: 785–799, 1971.PubMedGoogle Scholar
  5. 5.
    Bagdade JD, Bierman EL, Porte D Jr. The significance of basal insulin levels in the evaluation of the insulin response to glucose and non-diabetic subjects. J Clin Invest 46: 1549–1557, 1967.PubMedCrossRefGoogle Scholar
  6. 6.
    Polonsky KS, Given BD, Hirsch L et al. Quantitative study of insulin secretion and clearance in normal and obese subjects. J Clin Invest 81: 435–441, 1988.PubMedCrossRefGoogle Scholar
  7. 7.
    Modan M, Halkin H, Fuchs Z, Lusky A, Chetrit A, Segal P, Eshkol A, Almog S, Shefi M. Hyperinsulinemia—a link between glucose intolerance, obesity, hypertension, dyslipoproteinemia, elevated serum uric acid and internal cation imbalance. Diabete et Metabolisme 13: 37–580, 1987.Google Scholar
  8. 8.
    Modan M, Halkin H, Lusky A, Segal P, Fuchs Z, Chetrit A. Hyperinsulinemia is characterized by jointly disturbed plasma VLDL, LDL, and HDL levels. A population-based study. Arteriosclerosis 8: 227–236, 1988.PubMedCrossRefGoogle Scholar
  9. 9.
    Modan M, Halkin H. Hyperinsulinemia or increased sympathetic drive as links for obesity and hypertension. Diabetes Care 14: 470–487, 1991.PubMedCrossRefGoogle Scholar
  10. 10.
    Reaven GM. The role of insulin resistance in human disease. Diabetes 37: 1595–1607, 1988.PubMedCrossRefGoogle Scholar
  11. 11.
    Ferrannini E, Buzzigoli C, Bonadonna R, Giorico M, Oleggini M, Graziadei L, Pedrinelli R, Brandi L, Bevilacqua S. Insulin resistance in essential hypertension. N Engl J Med 317: 350–357. 1987.PubMedCrossRefGoogle Scholar
  12. 12.
    DeFronzo RA, Ferrannini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14: 173–194, 1991.PubMedCrossRefGoogle Scholar
  13. 13.
    Yudkin JS, Abnormalities of coagulation and fibrinolysis in insulin resistance. Diabetes Care 22 (Supp1.3): C25 - C30, 1999.PubMedGoogle Scholar
  14. 14.
    Brunzell JD, Hokanson JE. Dyslipidemia of central obesity and insulin resistance. Diabetes Care 22 (Suppl. 3): C10 - C13, 1999.PubMedGoogle Scholar
  15. 15.
    DeFronzo R, Tobin J, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and insulin resisatnce. Am J Physiol 237: E214 - E223, 1979.PubMedGoogle Scholar
  16. 16.
    Bergman RN, Prager R, Volund A, Olefsky M. Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic clamp. J Clin Invest 79: 790–800, 1987.PubMedCrossRefGoogle Scholar
  17. 17.
    Matsuda M, DeFronzo R. Insulin sensitivity indices obtained from oral glucose tolerance testing. Diabetes Care 22: 1462–1470, 1999.PubMedCrossRefGoogle Scholar
  18. 18.
    Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412–419, 1985.PubMedCrossRefGoogle Scholar
  19. 19.
    Katz A, Nambi SS, Mather K, et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 85: 2402–2410.Google Scholar
  20. 20.
    Laakso M. How good a marker is insulin level for insulin resistance? Am J Epidemiol 137: 959–965, 1993.PubMedGoogle Scholar
  21. 21.
    Ducimentiere P, Eschwege E, Papz L, Richard JL, Claude JR, Rosselin G. Relationship of plasma insulin to the incidence of myocardial infarction and coronary heart disease. Diabetologia 19: 205–210, 1980.CrossRefGoogle Scholar
  22. 22.
    Fontbonne A, Charles MA, Thibult N, Rochard JL, Claude JR, Warnet JM, Rosselin GE, Eschwege E. Hyperinsulinemia as a predictor of coronary heart disease mortality in a healthy population: the Paris Prospective Study, 15-year follow-up. Diabetologia, 34: 356–361, 1991.PubMedCrossRefGoogle Scholar
  23. 23.
    Depres J-P, Lamarche B, Mauriege P, Cantin B, Dagenais GR, Moorjani S, Lupien P-J. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med, 334: 952–957, 1996.CrossRefGoogle Scholar
  24. 24.
    McAuley KS, Williams SM, Mann JI, Walker RJ, Lewis-Barned NJ, Temple LA, Duncan AW. Diagnosing insulin resistance in the general population. Diabetes Care 24: 460–464, 2001.PubMedCrossRefGoogle Scholar
  25. 25.
    American Diabetes Association: Task Force on Standardization of the Insulin Assay (Task Force Report). Diabetes 45: 242–256, 1996.CrossRefGoogle Scholar
  26. 26.
    Olefsky JM, Kolterman OG, Scarlett JA. Insulin action and resistance in obesity and non-insulin-dependent type 2 diabetes mellitus. Am J Physiol 243: E15 - E30, 1982.PubMedGoogle Scholar
  27. 27.
    Su HY, Sheu, WH, Chin HM, Jeng CY, Reaven GM. Effect of weight loss on blood pressure and insulin resistance in normotensive and hypertensive obese individuals. Am J Hypertension 8: 1067–1071, 1995.CrossRefGoogle Scholar
  28. 28.
    Niskanen L, Uusitupa M, Sarlund H, Siitonen O, Paljarvi L, Laasko M. The effects of weight loss on insulin sensitivity, skeletal muscle composition, and capillary density in obese non-diabetic subjects. Int J Obes 20: 154–160, 1996.Google Scholar
  29. 29.
    Maggio CA, Pi-Sunyer FX. The prevention and treatment of obesity. Diabetes Care 20: 1744–1766, 1997.PubMedGoogle Scholar
  30. 30.
    Muscelli E, Camastra S, Catalano C, Galvan AQ, Ciociaro D, Baldi S, Ferrannini E. Metabolic and cardiovascular assessment in moderate obesity: effect of weight loss. J Clin Endocrinolo Metab 82: 2937–2943, 1997.CrossRefGoogle Scholar
  31. 31.
    Vague J. The degree of masculine differences of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease. Am J Clin Nutr 4: 20–34, 1956.PubMedGoogle Scholar
  32. 32.
    Kvist H, Sjostrom L, Tylen U. Adipose tissue volume determinations in women by computerized tomography: technical considerations. Int J Obesity 10: 53–67, 1986.Google Scholar
  33. 33.
    Kvist H, Chowdhury B, Gangard U, Tylen U, Sjostrom L. Total and visceral adipose tissue volume derived from measurements with computerized tomography in adult men and women: predictive equations. Am J Clin Nutr 48: 1351–13621, 1988.PubMedGoogle Scholar
  34. 34.
    Abate N, Burns D, Peshock RM, Garg, Grundy SM. Estimation of adipose tissue mass by magnetic resonance imaging: validation against dissection in human cadavers. J Lipid Res 35: 1490–1496, 1994.PubMedGoogle Scholar
  35. 35.
    Tataranni PA, Ravussin E. Use of dual X-ray absorptiometry in obese individuals. Am J Clin Nutr 55: 730–734, 1995.Google Scholar
  36. 36.
    Goodpaster BH, Kelley DE, Wing RR, Meier A, Thaete FL. Effects of weight loss on regional fat distribution and insulin sensitivity in obesity. Diabetes 48: 839–847, 1999.PubMedCrossRefGoogle Scholar
  37. 37.
    Banerji MA, Lebovitz HE. Insulin-sensitive and insulin-resistant variants in NIDDM. Diabetes 38: 784–792, 1989.PubMedCrossRefGoogle Scholar
  38. 38.
    Banerji MA, Chaiken RL, Gordon D, Kral JG, Lebovitz HE. Does infra-abdominal adipose tissue in black men determine whether NIDDM is insulin resistant or insulin-sensitive? Diabetes 44: 141–146, 1995.PubMedCrossRefGoogle Scholar
  39. 39.
    Banerji MA, Lebowitz J, Chaiken RL, Gordon D, Kral J, Lebovitz HE. Relationships of visceral adipose tissue and glucose disposal is independent of sex in black NIDDM subjects. Am J Physiol. 273:E425–E432., 1997.Google Scholar
  40. 40.
    Banerji MA, Lebovitz HL. Insulin action in black Americans with NIDDM. Diabetes Care 15: 1295–1302, 1992.PubMedCrossRefGoogle Scholar
  41. 41.
    Bergstrom RW, Newell-Morris LL, Leonetti DL. Association of elevated fasting C-peptide level and increased intra-abdominal fat distribution with development of NIDDM in Japanese-American men. Diabetes 39: 104–111, 1990.PubMedCrossRefGoogle Scholar
  42. 42.
    Boyko EJ, Fujimoto WY, Leonetti DL, Newell-Morris L. Visceral adiposity and risk for type 2 diabetes: A prospective study among Japanese-Americans. Diabetes Care 23: 465–471, 2000.PubMedCrossRefGoogle Scholar
  43. 43.
    Brochu, M., Tchernof, A., Isabelle, D., et al. What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women? J Clin Endocrinol Metab 86: 1020–1025, 2001.PubMedCrossRefGoogle Scholar
  44. 44.
    Knowler WC, Bennett PH, Hamman RF, Miller M. Diabetes incidence and prevalence in Pima Indians: A 19-fold greater incidence than in Rochester, Minnesota. Am J Epidemiol 108: 497–505, 1978.PubMedGoogle Scholar
  45. 45.
    Gautier, J., Milner, M.R., Elam, E., Chen, K., et al. Visceral adipose tissue is not increased in Pima Indians compared with equally obese Caucasians. Diabetologia 42: 28–34, 1999.PubMedCrossRefGoogle Scholar
  46. 46.
    Saloranta C, Groop L. Interactions between glucose and FFA metabolism in man. Diabetes Metab Rev 12: 15–36, 1996.PubMedGoogle Scholar
  47. 47.
    Boden G. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 46: 3–10, 1997.PubMedCrossRefGoogle Scholar
  48. 48.
    Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene. Nature 375: 425–432, 1994.CrossRefGoogle Scholar
  49. 49.
    Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, Lazar MA. The hormone resistin links obesity to diabetes. Nature 409: 307–312, 2001.PubMedCrossRefGoogle Scholar
  50. 50.
    Perseghin G, Price TB, Petersen KF, Roden M, Cline GW, Gerow K, Rothman DL, Shulman GI. Increased glucose transport-phosphorylation and muscle glycogen synthesis after exercise training in insulin-resistant subjects. N Engl J Med 335: 1357–1362. 1996.PubMedCrossRefGoogle Scholar
  51. 51.
    Colditz GA, Willet WC, Stampfer MJ, Manson JE, Hennkens CH, Arky RA, Speizer FE. Weight as a risk factor for clinical diabetes in women. Am J Epidemiol 132: 501–513, 1990.PubMedGoogle Scholar
  52. 52.
    Knowler WC, Pettit PJ, Savage PJ, Bennett PH. Diabetes incidence in Pima Indians: contributions of obesity and parental diabetes. Am J Epidemiol 113: 144–156, 1981.PubMedGoogle Scholar
  53. 53.
    Modan M, Karasik A, Halkin H, Fuchs Z, Lusky A, Shitrit A, Modan B. Effects of past and concurrent body mass index on prevalence of glucose intolerance and type 2 (non-insulin-dependent) diabetes and on insulin response: the Israel Study of Glucose Intolerance, Obesity, and Hypertension. Diabetologia 29: 82–89. 1996.CrossRefGoogle Scholar
  54. 54.
    Holbrook TL, Barrett-Connor E, Wingard DL. The association of lifetime weight and weight control patterns with diabetes among men and women in an adult community. Int J Obesity 13: 723–729, 1989.Google Scholar
  55. 55.
    Kahn SE. The importance of 13-cell failure in the development and progression of type 2 diabetes. J Clin Endocrinol Metab 86: 4047–4058, 2001.PubMedCrossRefGoogle Scholar
  56. 56.
    Ferrannini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleggini M, Graziadei L, Pedrinelli R, Brandi L, Bevilacqua S. Insulin resistance in essential hypertension. N Engl J Med 317: 350–357, 1987.PubMedCrossRefGoogle Scholar
  57. 57.
    Saad MF, Lillioja S, Nyomba BL, Castillo C, Ferraro R, De Gregorio M, Ravussin E, Knowler WC, Bennett PH, Howard BV, Bogardus C. Racial differences in the relation between blood pressure and insulin resistance. N Engl J Med 324: 733–739, 1991.PubMedCrossRefGoogle Scholar
  58. 58.
    Falkner B, Hulman S, Tannenbaum J, Kushner H. Insulin resistance and blood pressure in young black men. Hypertension 16: 706–711, 1990.PubMedCrossRefGoogle Scholar
  59. 59.
    Chaiken RL, Banerji MA, Huey H, Lebovitz HE. Do blacks with NIDDM have an insulin-resistance syndrome? Diabetes 42: 444–449, 1993.PubMedCrossRefGoogle Scholar
  60. 60.
    Burghen GA, Givens JR, Kitabchi AE. Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease. J Clin Endocrinol Metab 50: 113–116, 1980.PubMedCrossRefGoogle Scholar
  61. 61.
    Dunaif A, Graf M, Mandeli J et al. Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia. J Clin Endocrinol Metab 65: 499–507, 1987.PubMedCrossRefGoogle Scholar
  62. 62.
    Dunaif A, Thomas A. Current concepts in the polycystic ovary syndrome. Annu Rev Med 52: 401–419, 2001.PubMedCrossRefGoogle Scholar
  63. 63.
    Rizza RA, Mandarino LJ, Gerich JE. Mechanisms of insulin resistance in man. Assessment using the insulin dose-response curve in conjunction with insulin-receptor binding. Am J Med 70: 169–176, 1981.PubMedCrossRefGoogle Scholar
  64. 64.
    Fineberg SE, Merimee TJ, Rabinowitz D, Edgar PJ. Insulin secretion in acromegaly. J Clin Endocrinol Metab 30: 288–292, 1970.PubMedCrossRefGoogle Scholar
  65. 65.
    Fowelin J, Attvall S, Lager I, Bengtsson BA. Effects of treatment with recombinant human growth hormone on insulin sensitivity and glucose metabolism in adults with growth hormone deficiency. Metabolism 42: 1443–1447, 1993.PubMedCrossRefGoogle Scholar
  66. 66.
    Sesmilo G, Biller BMK, Lievadot J, Hayden D, Hanson G, Rifai N, Klibanski A. Effects of growth hormone administration on inflammatory and other cardiovascular risk markers in men with growth hormone deficiency. Ann Intern Med 133: 111–122, 2000.PubMedCrossRefGoogle Scholar
  67. 67.
    Alberti KGMM, Zimmet PZ for the WHO Consultation: Definition, diagnosis, and classification of diabetes mellitus and its complications. Part 1: Diagnosis and Classification of Diabetes Mellitus. Diabetic Medicine 15: 539–553, 1998.PubMedCrossRefGoogle Scholar
  68. 68.
    AACE: Diagnostic criteria and operational definition developed by American College of Clinical Endocrinologists. www.AACE.c om/members/socio/syndoi mex. php. 2001.Google Scholar
  69. 69.
    Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285: 2486–2496, 2001.CrossRefGoogle Scholar
  70. 70.
    Everson, S., Lynch JW, Goldberg, D., Kaplan GA, Helmrich, S., Salonen JT, Lakka TA. Weight gain and the risk of developing insulin resistance syndrome. Diabetes Care, 21: 1637–1643, 1998.PubMedCrossRefGoogle Scholar
  71. 71.
    Bonora, E., Kiechl, S., Willeit, J., Oberhollenzer, F., Egger G, Targher G, Alberiche M, Bonadonna RC, Muggeo M. Prevalence of Insulin resistance in metabolic disorders. The Bruneck Study. Diabetes, 47: 1643–1649, 1998.PubMedCrossRefGoogle Scholar
  72. 72.
    Flegal KM. The obesity epidemic in children and adults: current evidence and research issues. Med Sci Sports Exer 32 (suppl.11): S509–514, 1999.Google Scholar
  73. 73.
    American Diabetes Association. Type 2 diabetes in children and adolescents (consensus statement) Diabetes Care 23: 381–389, 2000.Google Scholar
  74. 74.
    Young-Hyman, D, DeLuca F, Schlundt D, Counts D, Herman L.: Evaluation of the Insulin resistance Syndrome in 5- to 10-year-old overweight/obese African-American children. Diabetes Care 24: 1359–1364, 2001.PubMedCrossRefGoogle Scholar
  75. 75.
    Isomaa, B, Lahti K, Almgren P, Nissen M, Tuomi T, Taskinen MR, Forsen B, Groop L.: Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24: 683–689, 2001.PubMedCrossRefGoogle Scholar
  76. 76.
    Haffner SM, Mykkanen L, Festa A, Burke JP, Stern MP.: Insulin resistant prediabetic subjects have more atherogenic risk factors than insulin-sensitive prediabetic subjects. Circulation 101: 975–980, 2000.PubMedCrossRefGoogle Scholar
  77. 77.
    Greenlund KJ, Rith-Najarian S, Valdez R, Croft JB, Casper ML.: Prevalence and correlates of the insulin resistance syndrome among Native Americans. Diabetes Care 22: 441–447, 1999.PubMedCrossRefGoogle Scholar
  78. 78.
    Howard G, O’Leary DH, Zaccaro D, Haffner S, Rewers M, Hamman R, Selby JV, Saad MF, Savage P, Bergman R, for the IRAS Investigators. Insulin sensitivity and atherosclerosis. Circulation 93: 1809–1817, 1996.PubMedCrossRefGoogle Scholar
  79. 79.
    Ferrara A, Barrett-Connor EL, Edelstein SL.: Hyperinsulinemia does not increase the risk of fatal cardiovascular disease in elderly men or women without diabetes: the Rancho Bernardo Study, 1984–1991. Am J Epidemiol 140: 857–869, 1994.PubMedGoogle Scholar
  80. 80.
    Rendell M, Hulthen UL, Tornquist C, Groop L, Mattiasson I.: Realtionship between abdominal fat compartments and glucose and lipid metabolism in early postmenopausal women. J Clin Endocrinol Metab 86: 744–749, 2001.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2004

Authors and Affiliations

  • Rochelle L. Chaiken

There are no affiliations available

Personalised recommendations